Not all people with CLL involve therapy. Even with all recent innovations, the iwCLL nevertheless suggests watchful observation for clients with asymptomatic ailment.86 This advice is based on no less than two randomized trials evaluating observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 Equ